Ji Eun Lee

Title: Ji Eun Lee: Innovator in Monoclonal Antibody Development

Introduction

Ji Eun Lee is a prominent inventor based in Koyang, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work focuses on the vascular cell adhesion molecule-1 (VCAM-1), which plays a crucial role in various diseases.

Latest Patents

Ji Eun Lee holds 1 patent for her invention of a VCAM-1 specific monoclonal antibody. This groundbreaking invention relates to an antibody that specifically binds to VCAM-1, which is also known as CD106. The monoclonal antibody is unique as it specifically targets both human and mouse VCAM-1. The invention includes methods for producing the antibody, as well as compositions for diagnosis or treatment that utilize it. The antibody demonstrates a strong affinity for VCAM-1 expressed in various cell types, including rat skeletal muscle and porcine endothelial cells. It has been shown to effectively inhibit the interaction between leukocytes and activated endothelial cells, making it a potential treatment for VCAM-1 mediated diseases, particularly inflammatory diseases and cancer.

Career Highlights

Ji Eun Lee is currently employed at Hanwha Chemical Corporation, where she continues her research and development efforts. Her work has positioned her as a key figure in the field of monoclonal antibody research.

Collaborations

Ji Eun Lee collaborates with notable colleagues, including Junho Chung and Eun Kyung Ryu, who contribute to her research initiatives and projects.

Conclusion

Ji Eun Lee's innovative work in developing a VCAM-1 specific monoclonal antibody showcases her dedication to advancing medical science. Her contributions have the potential to significantly impact the treatment of various diseases.